Related Experiment Video
Updated: Jun 20, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Anticoagulant management in patients with atrial fibrillation
David A Fitzmaurice1, F D Richard Hobbs
1University of Birmingham, Birmingham, United Kingdom.
Insights
Atrial fibrillation (AF) increases stroke risk, but anticoagulation with warfarin significantly reduces this risk. Effective management involves identifying high-risk patients and maintaining proper anticoagulation control to minimize bleeding complications.
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia.
- AF significantly elevates the risk of embolic stroke, contributing to 15% of all strokes and 30% in individuals over 75.
- Anticoagulation therapy is crucial for stroke risk reduction in AF patients.
Purpose of the Study:
- To highlight the importance of identifying patients with atrial fibrillation.
- To emphasize the need for appropriate treatment strategies, particularly for high-risk individuals.
- To underscore the role of anticoagulation in preventing stroke.
Main Methods:
- Review of existing literature on atrial fibrillation, stroke risk, and anticoagulation.
- Analysis of the efficacy of warfarin in reducing stroke risk.
- Discussion of anticoagulation control parameters, specifically the International Normalized Ratio (INR).
Main Results:
- Warfarin therapy can decrease stroke risk by approximately two-thirds.
- Maintaining INR within the 2.0 to 3.0 range (target 2.5) minimizes bleeding risks associated with anticoagulation.
- Efficient identification and risk stratification of AF patients are essential for public health impact.
Conclusions:
- Effective management of atrial fibrillation requires timely diagnosis and risk assessment.
- Anticoagulation, primarily with warfarin, is a cornerstone in preventing AF-related strokes.
- Optimizing anticoagulation control is vital for balancing stroke prevention and bleeding risk.
Abstract:
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a high risk of embolic stroke (cause in 15% of all strokes and 30% of strokes in those >75 years of age). Anticoagulation with warfarin will reduce stroke risk by about two thirds. The main risks of anticoagulation, namely bleeding, can be minimized by maintaining anticoagulation control within the international normalized range range of 2.0 to 3.0 (target: 2.5). To have a public health impact, patients with AF need efficient and correct identification, with appropriate treatment directed at those patients at most risk from the condition.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Aortic Regurgitation III: Medical Management
Pulmonary Embolism III: Nursing Management
